Alignment Healthcare, Inc.·4

Apr 15, 8:41 PM ET

Maroney Dawn Christine 4

4 · Alignment Healthcare, Inc. · Filed Apr 15, 2026

Research Summary

AI-generated summary of this filing

Updated

Alignment Healthcare (ALHC) President Dawn Maroney Sells 30,000 Shares

What Happened
Dawn Christine Maroney, President of Alignment Healthcare, sold 30,000 shares on April 15, 2026. The reported weighted‑average sale price was $20.87 per share (range $20.76–$21.07), producing gross proceeds of about $626,199. The transaction is reported as a sale (code S) and was executed via open‑market or private sale per the filing.

Key Details

  • Transaction date: 2026-04-15.
  • Shares sold: 30,000; weighted‑average price: $20.87; per‑share price range: $20.76–$21.07.
  • Reported proceeds: approximately $626,199.
  • Shares owned after the transaction: not specified in the provided excerpt of the filing.
  • Footnotes: (F1) a Rule 10b5‑1 plan was adopted on 05/22/2025; (F2) the filing reports a weighted‑average price and the seller can provide a breakdown of shares sold at each price within the stated range.
  • Timeliness: Filing period and file date are both 2026-04-15, indicating a timely report.

Context
The presence of a Rule 10b5‑1 trading plan (adopted 05/22/2025) suggests these sales may have been pre‑scheduled, which can reduce implications about the insider’s view of the company. Sales are common and can be driven by personal liquidity or diversification needs; unlike purchases, they are generally less informative about insider sentiment. The weighted‑average price and range indicate multiple executions; the filer offers to provide a per‑price breakdown on request.

Insider Transaction Report

Form 4
Period: 2026-04-15
Transactions
  • Sale

    Common Stock

    [F1][F2]
    2026-04-15$20.87/sh30,000$626,1991,028,813 total
Footnotes (2)
  • [F1]Date of Rule 10b5-1 plan adoption: 05/22/2025
  • [F2]The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $20.76 to $21.07. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.
Signature
/s/ Christopher J. Joyce, as Attorney-in-Fact, for Dawn C. Maroney|2026-04-15

Documents

1 file
  • 4
    wk-form4_1776300091.xmlPrimary

    FORM 4